IPG Investment Advisors LLC purchased a new stake in shares of Tenet Healthcare Corporation (NYSE:THC - Free Report) in the third quarter, according to its most recent disclosure with the SEC. The firm purchased 11,067 shares of the company's stock, valued at approximately $2,828,000.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in THC. Manning & Napier Advisors LLC acquired a new position in Tenet Healthcare in the 2nd quarter worth $168,761,000. Arrowstreet Capital Limited Partnership grew its stake in shares of Tenet Healthcare by 57.4% during the first quarter. Arrowstreet Capital Limited Partnership now owns 671,700 shares of the company's stock valued at $126,757,000 after acquiring an additional 244,901 shares in the last quarter. Bank of New York Mellon Corp acquired a new stake in shares of Tenet Healthcare during the second quarter valued at about $106,342,000. Empowered Funds LLC increased its position in shares of Tenet Healthcare by 22.1% during the first quarter. Empowered Funds LLC now owns 284,753 shares of the company's stock worth $53,736,000 after acquiring an additional 51,549 shares during the last quarter. Finally, First Trust Advisors LP increased its position in shares of Tenet Healthcare by 11.8% during the first quarter. First Trust Advisors LP now owns 240,019 shares of the company's stock worth $45,294,000 after acquiring an additional 25,263 shares during the last quarter. Hedge funds and other institutional investors own 95.44% of the company's stock.
Wall Street Analyst Weigh In
A number of brokerages recently commented on THC. Wells Fargo & Company increased their price target on Tenet Healthcare from $281.00 to $321.00 and gave the company an "overweight" rating in a report on Monday. BMO Capital Markets initiated coverage on Tenet Healthcare in a report on Tuesday, September 22nd. They set a "market perform" rating and a $265.00 price objective on the stock. Weiss Ratings raised Tenet Healthcare from a "buy (b-)" rating to a "buy (b)" rating in a research report on Thursday, October 8th. KeyCorp increased their target price on Tenet Healthcare from $270.00 to $300.00 and gave the company an "overweight" rating in a research note on Tuesday. Finally, Truist Financial reiterated a "buy" rating and set a $305.00 target price (up from $290.00) on shares of Tenet Healthcare in a research note on Tuesday. Eighteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, Tenet Healthcare currently has an average rating of "Moderate Buy" and a consensus target price of $290.63.
Get Our Latest Stock Analysis on THC
Insider Buying and Selling
In related news, Director Richard J. Mark sold 10,000 shares of the stock in a transaction dated Thursday, September 10th. The shares were sold at an average price of $263.42, for a total transaction of $2,634,200.00. Following the sale, the director owned 25,121 shares in the company, valued at $6,617,373.82. This represents a 28.47% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director J. Robert Kerrey sold 12,010 shares of the stock in a transaction dated Monday, September 14th. The stock was sold at an average price of $263.72, for a total transaction of $3,167,277.20. Following the sale, the director owned 4,794 shares in the company, valued at approximately $1,264,273.68. This trade represents a 71.47% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 105,884 shares of company stock worth $28,740,455. Company insiders own 0.97% of the company's stock.
Tenet Healthcare Price Performance
Shares of THC opened at $266.48 on Wednesday. Tenet Healthcare Corporation has a 52 week low of $157.58 and a 52 week high of $283.05. The company has a current ratio of 1.58, a quick ratio of 1.52 and a debt-to-equity ratio of 1.76. The firm has a market cap of $21.21 billion, a price-to-earnings ratio of 7.73, a PEG ratio of 1.44 and a beta of 1.20. The stock has a 50 day moving average of $264.37 and a 200-day moving average of $221.04.
Tenet Healthcare (NYSE:THC - Get Free Report) last announced its quarterly earnings data on Thursday, October 29th. The company reported $6.64 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.68 by $1.96. Tenet Healthcare had a return on equity of 28.22% and a net margin of 13.09%. The firm had revenue of $6.28 billion for the quarter, compared to analysts' expectations of $5.49 billion. During the same period last year, the business posted $3.70 earnings per share. The firm's revenue for the quarter was up 6.5% on a year-over-year basis. As a group, analysts forecast that Tenet Healthcare Corporation will post 22.31 EPS for the current year.
More Tenet Healthcare News
Here are the key news stories impacting Tenet Healthcare this week:
- Positive Sentiment: Analysts raised their targets and maintained bullish ratings: Truist lifted its target to $305 and reaffirmed “Buy,” KeyCorp raised its target to $300 with an “Overweight” rating, and Leerink Partners, RBC and Wells Fargo also increased targets, to $342, $304 and $321, respectively.
- Positive Sentiment: A report said Tenet raised its 2026 EBITDA outlook following its third-quarter results, a sign of improved expectations for operating performance. Tenet Healthcare stock after Q3: 2026 EBITDA outlook raised
- Negative Sentiment: Guggenheim reportedly trimmed its price target, a counterpoint to the cluster of upward revisions; the provided headline did not specify the revised target or rating. Tenet Healthcare stock gets price target trim from Guggenheim
Tenet Healthcare Profile
(
Free Report)
Tenet Healthcare Corp. NYSE: THC is a diversified healthcare services company headquartered in Dallas, Texas. Through its hospital operations and outpatient platforms, the company provides a range of medical services to patients across the United States.
Tenet operates acute care and specialty hospitals, ambulatory surgery centers, imaging facilities and other outpatient care sites. Its United Surgical Partners International subsidiary is a major provider of ambulatory surgery services and partners with physicians and health systems.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Tenet Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tenet Healthcare wasn't on the list.
While Tenet Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.
This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.